The Star in Clay Siegall

Clay Siegall in his WordPress page has written a lot of educative posts. On 6th March, he wrote on what to do when a Lyme-infested tick bites you. He was driven to write due to the spread of Lyme in the mid-Atlantic region. The figures from research show that the number of Lyme cases reported have doubled from 2001 to 2015. Clay also explained on the effects of Lyme, which include flu like symptoms and arthritis. He further explained that one should always be on the lookout for ticks. He gave a guide on what to do when one spots a tick; relax, use tweezers to pull out the head of the tick, check whether the tick you picked is from a Lyme infested area, take the tick to a lab for study and monitor to see if you have got any Lyme related infection.


On 4th March 2017, Siegall wrote on how a doctor launched a vision to help astronauts’ eyeballs. Siegall explained how a doctor had done research and found out that after spending too much in space, one’s vision usually changes; one generally struggles to read. The scientific explanation to this was that while in space, the fluid around the heart moves to the head and causes damage to one’s vision. This was due to the anti-gravity state, but doctors were working to resolve the issue.


Clay B. Siegall is the co-founder of Seattle Genetics, which he founded in the year 1998, and is the Chairman of the Board, the company’s President, and the Chief Executive Officer. He is a scientist with emphasis on targeted cancer therapies. He built his foundation with the main aim of attaining scientific innovation, religious research and drug development practices. Under Clay’s leadership, the company has been guided to securing the 2011 FDA approval of its first ADC products. Seattle Genetics has collaborated with Takeda Pharmaceutical Company, and is now a brand approved in 65 countries. Dr. Siegall has also led Seattle Genetics’ fund raising activities by raising more than $1.2 billion. Previously, Dr. Siegall had worked with the National Cancer Institute, Bristol-Myers Squibb Pharmaceutical Research Institute, and the National Institutes of Health.

Leave a Reply

Your email address will not be published. Required fields are marked *